PetVivo (NASDAQ:PETV) Hits New 1-Year High – Should You Buy?

PetVivo Holdings, Inc. (NASDAQ:PETVGet Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $73.50 and last traded at $73.50, with a volume of 12799 shares trading hands. The stock had previously closed at $0.78.

PetVivo Stock Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 0.42 and a quick ratio of 0.47. The stock has a market capitalization of $22.53 million, a PE ratio of -1.44 and a beta of 1.13. The firm has a fifty day moving average price of $1.02 and a two-hundred day moving average price of $1.06.

About PetVivo

(Get Free Report)

PetVivo, Inc, headquartered in Ormond Beach, Florida, is a regenerative biomedical technology company specializing in veterinary applications. The company’s core focus is on developing and commercializing sustained-release intra-articular therapies for animals through its proprietary RediVet injectable micro-plug system. This biodegradable polymer platform is designed to provide controlled release of therapeutic agents directly into joints, targeting osteoarthritis and related inflammatory conditions in companion and performance animals.

PetVivo’s lead product, the RediVet-40 system, has been evaluated in proof-of-concept trials involving canine patients with osteoarthritis.

See Also

Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.